taVNS for Upper Limb Rehabilitation
- Conditions
- Stroke
- Interventions
- Device: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training
- Registration Number
- NCT04129242
- Lead Sponsor
- Medical University of South Carolina
- Brief Summary
This study explores the use of a new form of neuromodulation known as transcutaneous auricular vagus nerve stimulation (taVNS) which stimulates the ear. This stimulation will be delivered concurrently with upper limb motor rehabilitation training (3 days/week for 4 weeks) in chronic stroke patients. Patients will undergo a series of baseline assessments (including a brain scan), a 4-week course of motor rehabilitation, and post-assessments (including a second brain scan)
- Detailed Description
This study aims to refine and develop closed loop taVNS, establish activity with key biomarkers, and show initial feasibility in a small clinical trial. For paired taVNS to succeed as a clinical treatment, it is critical to develop and refine a closed-loop taVNS platform that delivers stimulation concurrently during specific movements of the motor rehabilitation training.
Aim 1 develops this novel motion-gated closed-loop system that delivers taVNS in synchrony with specific upper limb motor activation (n=5) Aim 2 will combine the development of the closed-loop system with the investigator's mechanistic understanding to explore an open-label pilot trial (n=20) using closed-loop taVNS paired with task-specific training to determine the feasibility, safety, and potential effect size of this novel combination therapy.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 20
- 18-80 years old
- Ischemic or hemorrhagic stroke that occurred at least 6 months prior
- Completed conventional rehabilitation therapy at least one month prior
- Unilateral limb weakness with Fugl Meyer-Upper Extremity Scale score less than or equal to 58 (out of 66)
- Primary intracerebral hematoma, or subarachnoid hemorrhage
- Bilateral upper extremity weakness
- Other concomitant neurological disorders affecting upper extremity motor function
- Documented history of dementia before or after stroke
- Documented history of uncontrolled depression or psychiatric disorder either before or after stroke which could affect their ability to participate in the experiment
- Uncontrolled hypertension despite treatment, specifically SBP (Systolic Blood Pressure) / DBP (Diastolic Blood Pressure) >=180/100mmHg at baseline
- Contraindicated for MRI scanning.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description "unpaired" taVNS + Task Specific Training Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training - "paired" taVNS + Task Specific Training Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) + Task Specifc Training -
- Primary Outcome Measures
Name Time Method Change in Fugl-Meyer Assessment of the Upper Extremity Mean change in FMA-UE score after 4 weeks of rehab, compared to baseline The Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) is a stroke rehabilitation assessment of arm/hand movement impairment. It is scored by assigning 30 items assessing voluntary arm/hand movements and 3 items assessing reflexes an ordinal rating (0=unable, 1=partial, 2=near normal), then summing the ratings to obtain a general statement of ability. Possible aggregate scores range from 0/66 to 66/66 points. Higher scores indicate greater levels of arm movement ability.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Medical University of South Carolina
🇺🇸Charleston, South Carolina, United States